Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 22:31:101095.
doi: 10.1016/j.omtm.2023.08.014. eCollection 2023 Dec 14.

iMSC: One leap closer to clinical applications

Duc M Hoang  1
Affiliations

iMSC: One leap closer to clinical applications

Duc M Hoang. Mol Ther Methods Clin Dev. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The author reports no conflicts of interest.

References

    1. Li M., Tang H., Li Z., Tang W. Emerging Treatment Strategies for Cerebral Ischemia-Reperfusion Injury. Neuroscience. 2022;507:112–124. doi: 10.1016/j.neuroscience.2022.10.020. - DOI - PubMed
    1. Hoang D.M., Pham P.T., Bach T.Q., Ngo A.T.L., Nguyen Q.T., Phan T.T.K., Nguyen G.H., Le P.T.T., Hoang V.T., Forsyth N.R., et al. Stem cell-based therapy for human diseases. Signal Transduct. Target. Ther. 2022;7:272. doi: 10.1038/s41392-022-01134-4. - DOI - PMC - PubMed
    1. Bloor A.J.C., Patel A., Griffin J.E., Gilleece M.H., Radia R., Yeung D.T., Drier D., Larson L.S., Uenishi G.I., Hei D., et al. Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation study. Nat. Med. 2020;26:1720–1725. doi: 10.1038/s41591-020-1050-x. - DOI - PubMed
    1. Arakawa M., Sakamoto Y., Miyagawa Y., Nito C., Takahashi S., Nitahara-Kasahara Y., Suda S., Yamazaki Y., Sakai M., Kimura K., Okada T. iPSC-derived mesenchymal stem cells attenuate cerebral ischemia-reperfusion injury by inhibiting inflammatory signaling and oxidative stress. Mol Ther Methods Clin Dev. 2023;30:333–349. doi: 10.1016/j.omtm.2023.07.005. - DOI - PMC - PubMed
    1. Nguyen Q.T., Thanh L.N., Hoang V.T., Phan T.T.K., Heke M., Hoang D.M. Bone Marrow-Derived Mononuclear Cells in the Treatment of Neurological Diseases: Knowns and Unknowns. Cell. Mol. Neurobiol. 2023 doi: 10.1007/s10571-023-01377-x. - DOI - PMC - PubMed

LinkOut - more resources